Key facts
- This page summarizes Kristi Jones's Form 4 filing for NexImmune, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Jun 2024, 19:58.
Kristi Jones - 11 Jun 2024 Form 4 Insider Report for NexImmune, Inc.
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 11 Jun 2024
- Net transaction value
- +$0.01
- SEC form
- 4
- Accepted by SEC
- 13 Jun 2024, 19:58:48 UTC
- Prior SEC filing
- 06 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/John Rudy, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kristi Jones filed Form 4 for NexImmune, Inc. on 13 Jun 2024.
Change
- Previous filing in this sequence was filed on 06 Apr 2023.
- Current net transaction value: +$0.01.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEXI
transaction
Series A Preferred Stock, par value $0.0001 per share
Purchase
- Transaction value
- $0.01
- Shares
- +1
- Change %
- Price
- $0.0100*
- Shares after
- 1
- Date
- 11 Jun 2024
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On June 11, 2024, the Reporting Person purchased one (1) share of Series A Preferred Stock, par value $0.0001 per share (the "Preferred Stock"), of NexImmune, Inc. (the "Issuer") from the Issuer for cash consideration of $0.01. The Preferred Stock has the rights, preferences, privileges and restrictions set forth in the Certificate of Designation of Series A Preferred Stock filed by the Issuer with the Secretary of State of the State of Delaware on June 11, 2024 (the "Series A COD"), including the right to have a number of votes equal to the number of outstanding shares of common stock,
Footnote F2
(Continued from footnote 1) par value $0.0001 per share ("Common Stock") on the record date for determining stockholders entitled to vote on such voting proposals defined in the Series A COD if the aggregate number of shares of Common Stock, present in person or by proxy and entitled to vote thereon that voted "for" a voting proposal is greater than the aggregate number of shares of Common Stock present in person or by proxy and entitled to vote thereon that voted "against" or "abstain" on such voting proposal.